Cargando…

The Pulmonary Fibrosis Associated MUC5B Promoter Polymorphism Is Prognostic of the Overall Survival in Patients with Non–Small Cell Lung Cancer (NSCLC) Receiving Definitive Radiotherapy()()()

BACKGROUND: MUC5B is glycoprotein secreted by bronchial glands. A promoter variant in MUC5B, rs35705950, was previously found to be strongly associated with the incidence of idiopathic pulmonary fibrosis (IPF) and also the overall survival (OS) of such patients. Patients with IPF and patients with r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Ju, Xu, Ting, Gomez, Daniel R., Jeter, Melenda, Levy, Lawrence B, Song, Yipeng, Hahn, Stephen, Liao, Zhongxing, Yuan, Xianglin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2017
Materias:	Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5300294/ https://www.ncbi.nlm.nih.gov/pubmed/28189065 http://dx.doi.org/10.1016/j.tranon.2016.12.009

Ejemplares similares

Polymorphisms in BMP2/BMP4, with estimates of mean lung dose, predict radiation pneumonitis among patients receiving definitive radiotherapy for non-small cell lung cancer
por: Yang, Ju, et al.
Publicado: (2017)

Nomograms incorporating genetic variants in BMP/Smad4/Hamp pathway to predict disease outcomes after definitive radiotherapy for non‐small cell lung cancer
por: Yang, Ju, et al.
Publicado: (2018)

Polymorphisms of Homologous Recombination Genes and Clinical Outcomes of Non-Small Cell Lung Cancer Patients Treated with Definitive Radiotherapy
por: Yin, Ming, et al.
Publicado: (2011)

TGFβ1 Polymorphisms Predict Distant Metastasis–Free Survival in Patients with Inoperable Non-Small-Cell Lung Cancer after Definitive Radiotherapy
por: Yuan, Xianglin, et al.
Publicado: (2013)

Prognosis of severe lymphopenia after postoperative radiotherapy in non-small cell lung cancer: Results of a long-term follow up study
por: Jing, Wang, et al.
Publicado: (2021)

Predictive performance of different NTCP techniques for radiation-induced esophagitis in NSCLC patients receiving proton radiotherapy
por: Chen, Mei, et al.
Publicado: (2022)

The overall survival benefit in Chinese ALK(+) NSCLC patients received targeted therapies
por: Tian, Guangming, et al.
Publicado: (2022)

Heart Dosimetric Parameters Were Associated With Cardiac Events and Overall Survival for Patients With Locally Advanced Esophageal Cancer Receiving Definitive Radiotherapy
por: Cai, Guoxin, et al.
Publicado: (2020)

Diffusion-weighted MRI improves response assessment after definitive radiotherapy in patients with NSCLC
por: Philippe, Jagoda, et al.
Publicado: (2021)

Association of Long-term Outcomes and Survival With Multidisciplinary Salvage Treatment for Local and Regional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer
por: Brooks, Eric D., et al.
Publicado: (2018)

Correction to: Diffusion-weighted MRI improves response assessment after definitive radiotherapy in patients with NSCLC
por: Jagoda, Philippe, et al.
Publicado: (2021)

Radiological Assessment in Idiopathic Pulmonary Fibrosis (IPF) Patients According to MUC5B Polymorphism
por: Cocconcelli, Elisabetta, et al.
Publicado: (2022)

Phase I Study of Celecoxib with Concurrent Irinotecan, Cisplatin, and Radiation Therapy for Patients with Unresectable Locally Advanced Non-Small Cell Lung Cancer
por: Komaki, Ritsuko, et al.
Publicado: (2011)

The Impact of Lymphopenia and Dosimetric Parameters on Overall Survival of Esophageal Cancer Patients Treated with Definitive Radiotherapy
por: Liu, Ming, et al.
Publicado: (2021)

The impact of pathologic staging of the hilar/mediastinal nodes on outcomes in patients with early-stage NSCLC receiving stereotactic body radiotherapy
por: Mullins, Brandon T., et al.
Publicado: (2021)

Treatment-duration is related to changes in peripheral lymphocyte counts during definitive radiotherapy for unresectable stage III NSCLC
por: Zhao, Qianqian, et al.
Publicado: (2019)

Post-operative radiotherapy in NSCLC.
por: Stewart, L., et al.
Publicado: (1997)

Infection and Inflammation MUC up the Cystic Fibrosis Airway
por: Ma, Jonathan
Publicado: (2022)

Single nucleotide polymorphisms within MUC4 are associated with colorectal cancer survival
por: Lu, Shun, et al.
Publicado: (2019)

Prognostic Factors for Patients with Esophageal Cancer Receiving Definitive Radiotherapy Alone: A Retrospective Analysis
por: Jiang, Nan, et al.
Publicado: (2021)

Radiotherapy and MVA-MUC1-IL-2 vaccine act synergistically for inducing specific immunity to MUC-1 tumor antigen
por: Hillman, Gilda G., et al.
Publicado: (2017)

Correction: Single nucleotide polymorphisms within MUC4 are associated with colorectal cancer survival
por: Lu, Shun, et al.
Publicado: (2019)

Machine Learning of Dose-Volume Histogram Parameters Predicting Overall Survival in Patients with Cervical Cancer Treated with Definitive Radiotherapy
por: Xu, Zhiyuan, et al.
Publicado: (2022)

Polymorphisms of MUC16 (CA125) and MUC1 (CA15.3) in Relation to Ovarian Cancer Risk and Survival
por: Williams, Kristina A., et al.
Publicado: (2014)

Differences in Treatment Outcomes and Prognosis between Elderly and Younger Patients Receiving Definitive Radiotherapy for Cervical Cancer
por: Hou, PeiYu, et al.
Publicado: (2020)

Prognostic significance of platelet-to-albumin ratio in patients with esophageal squamous cell carcinoma receiving definitive radiotherapy
por: Huang, Zhiyu, et al.
Publicado: (2022)

Mucin Variable Number Tandem Repeat Polymorphisms and Severity of Cystic Fibrosis Lung Disease: Significant Association with MUC5AC
por: Guo, XueLiang, et al.
Publicado: (2011)

Low neutrophil-to-lymphocyte ratio predicts overall survival benefit in advanced NSCLC patients with low PD-L1 expression and receiving chemoimmunotherapy
por: Chen, Chian-Wei, et al.
Publicado: (2023)

The Possible Pathogenesis of Idiopathic Pulmonary Fibrosis considering MUC5B
por: Zhang, Qinghua, et al.
Publicado: (2019)

The Integrated Stress Response Links Muc5b to Pulmonary Fibrosis
por: Herrerias, Mariana M., et al.
Publicado: (2022)

MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance
por: Betge, Johannes, et al.
Publicado: (2016)

Stereotaktische Radiotherapie plus Nivolumab bei NSCLC
por: Krug, David, et al.
Publicado: (2023)

Development of anti-MUC1 DNA aptamers for the imaging and radiotherapy of breast cancer
por: Da Pieve, C, et al.
Publicado: (2006)

Development of anti-MUC1 DNA aptamers for the imaging and radiotherapy of breast cancer
por: Da Pieve, C, et al.
Publicado: (2008)

Impact of Cardiac Dose on Overall Survival in Lung Stereotactic Body Radiotherapy (SBRT) Compared to Conventionally Fractionated Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC)
por: Anderson, Justin D., et al.
Publicado: (2021)

Definitive Radiotherapy versus Postoperative Radiotherapy for Tonsil Cancer
por: Koo, Tae Ryool, et al.
Publicado: (2012)

Optimal Definition of Biochemical Recurrence in Patients Who Receive Salvage Radiotherapy Following Radical Prostatectomy for Prostate Cancer
por: Lee, Sung Uk, et al.
Publicado: (2022)

Patterns of nodal spread in stage III NSCLC: importance of EBUS-TBNA and (18)F-FDG PET/CT for radiotherapy target volume definition
por: Guberina, Maja, et al.
Publicado: (2021)

Quality of Life in Patients with NSCLC Receiving Maintenance Therapy
por: Rittmeyer, Achim
Publicado: (2015)

MUC7 VNTR polymorphism and association with bronchial asthma in Egyptian children
por: Saad, Entsar A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qhvhqtdjt5k1gqo1rpd6hs0q0i